Sigyn Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONVERTIBLE NOTE PAYABLE (Details Narrative)

CONVERTIBLE NOTE PAYABLE (Details Narrative) - USD ($)			1 Months Ended		3 Months Ended		12 Months Ended
CONVERTIBLE NOTE PAYABLE (Details Narrative) - USD ($)	May 30, 2017	Dec. 02, 2016	Dec. 31, 2016	Nov. 30, 2016	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2015
Successor [Member]
Interest expense					$ 189,162
Derivative liabilities			$ 153,663		$ 188,465
Successor [Member] \| December 2015 Purchaser Conversion [Member]
Description of terms of conversion feature					December 2015 Purchaser Conversion Price of $0.12, subject to potential future adjustments described below. If the total outstanding balance of the Note were convertible as of December 31, 2016, the December 2015 Note would have been convertible into 7,187,500 shares of our common stock.
Successor [Member] \| November 2016 Notes [Member]
Unamortized debt discount					$ 210,045
Interest expense					46,677
Successor [Member] \| November 2015 Notes [Member]
Unamortized debt discount					132,208
Interest expense					141,651
Successor [Member] \| December 2015 Optional Redemption [Member]
Derivative liabilities					122,528
Re-measurement of derivative liability					25,180
Contingent fair value					$ 199,150
Successor [Member] \| Common Stock [Member]
Value of shares issued		$ 770,000
Number of shares issued		7,000,000
Successor [Member] \| Warrant [Member]
Share price (in dollars per share)			$ 0.11		$ 0.12
Successor [Member] \| Warrant [Member] \| November 2016 Notes [Member]
Unamortized debt discount					$ 283,172
Number of common shares issued					100,002
Warrants granted					$ 108,567
Successor [Member] \| Warrant [Member] \| November 2015 Notes [Member]
Unamortized debt discount					$ 862,500
Number of common shares issued					625,000
Warrants granted					$ 439,107
Debt origination expenses					$ 429,000
Successor [Member] \| November 2016 Purchaser Conversion Shares [Member]
Conversion rate					$ 0.12
Embedded derivative liability					$ 32,016
Accretion of debt discount					2,395,850
Derivative liabilities					26,610
Re-measurement of derivative liability					$ 2,615
Successor [Member] \| November 2016 Purchaser Warrants [Member]
Conversion rate					$ 0.12
Embedded derivative liability					$ 108,597
Trading period					5 years
Issuance date					6 months
Share price (in dollars per share)					$ 0.30
Derivative liabilities					$ 105,168
Re-measurement of derivative liability					$ 170
Successor [Member] \| November 2016 Purchaser Common Stock [Member]
Embedded derivative liability			$ 240,615
Value of shares issued				$ 833,354
Number of shares issued			244,945	100,002
Successor [Member] \| December 2015 Purchaser Conversion [Member]
Conversion rate					$ 0.12
Accretion of debt discount					$ 7,187,500
Derivative liabilities					39,327
Re-measurement of derivative liability					7,007
Derivative fair value					$ 88,983
Successor [Member] \| December 2015 Purchaser Warrants [Member]
Conversion rate					$ 0.12
Trading period					5 years
Issuance date					6 months
Derivative liabilities					$ 45,932
Share price (in dollars per share)					$ 0.30
Re-measurement of derivative liability					$ 413,890
Derivative fair value					439,107
Successor [Member] \| Securities Purchase Agreement [Member]
Issuance date			Nov. 10, 2016				Dec. 23, 2015
Description of terms of conversion feature			(ii) a November 2016 Note with a principal amount of $1.00 for each $0.86956 for each $1.00 paid by each purchaser for such purchaser’s November 2016 Note; and (iii) November 2016 Warrants to purchase up to a number of shares of Common Stock equal to 100% of such purchaser’s November 2016 Note principal amount divided by $0.12 (“Purchaser Conversion Price”), the conversion price in effect on the Initial Closing Date, with a per share exercise price equal to $0.30, subject to adjustment.				(ii) a Note with a principal amount of $1.00 for each $0.86956 for each $1.00 paid by each purchaser for such purchasers Note; and (iii) Warrants to purchase up to a number of shares of Common Stock equal to 100% of such purchasers Note principal amount divided by $0.12 (Purchaser Conversion Price), the conversion price in effect on the Initial Closing Date, with a per share exercise price equal to $0.30, subject to adjustment.
Issuance of convertible debt			$ 244,945				$ 724,500
Unamortized debt discount			$ 42,557				$ 138,000
Maturity date			May 10, 2018				Jun. 23, 2017
Interest rate			15.00%				15.00%
Conversion rate			$ 0.12				$ 0.12
Percentage of beneficially own in excess of common shares outstanding			9.99%				9.99%
Percentage of right to participate subsequent financing			100.00%				100.00%
Description of redemption of debt intrument			The Notes provide that commencing six (6) months after the Original Issue Date, we will have the option of prepaying the outstanding principal amount of the Notes (an Optional Redemption), in whole or in part, by paying to the holders a sum of money in cash equal to one hundred percent (100%) of the principal amount to be redeemed, together with accrued but unpaid interest thereon, if any, and any and all other sums due, accrued or payable to the holder arising under the Note through the Redemption Payment Date and 2.8986 shares of our Common Stock for each $1.00 of Note principal amount being redeemed. A Notice of Redemption, if given, may be given on the first Trading Day following twenty (20) consecutive Trading Days during which all of the Equity Conditions, as defined, have been in effect.				The Notes provide that commencing six (6) months after the Original Issue Date, we will have the option of prepaying the outstanding principal amount of the Notes (an Optional Redemption), in whole or in part, by paying to the holders a sum of money in cash equal to one hundred percent (100%) of the principal amount to be redeemed, together with accrued but unpaid interest thereon, if any, and any and all other sums due, accrued or payable to the holder arising under the Note through the Redemption Payment Date and 2.8986 shares of our Common Stock for each $1.00 of Note principal amount being redeemed. A Notice of Redemption, if given, may be given on the first Trading Day following twenty (20) consecutive Trading Days during which all of the Equity Conditions, as defined, have been in effect.
Embedded derivative liability					$ 88,983
Share price (in dollars per share)			$ 0.11		$ 0.12
Successor [Member] \| Securities Purchase Agreement [Member] \| Common Stock [Member]
Common stock convertible shares					2,500,000
Common stock convertible amount					$ 625,000
Successor [Member] \| Securities Purchase Agreement [Member] \| Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member] \| Secured Convertible Notes [Member]
Principle amount			$ 287,502				$ 862,500
Successor [Member] \| Securities Purchase Agreement [Member] \| Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member] \| Common Stock [Member]
Common stock convertible shares			833,354				2,500,000
Successor [Member] \| Securities Purchase Agreement [Member] \| Alpha Capital Anstalt and Brio Capital Master Fund Ltd. [Member] \| Warrant [Member]
Common stock convertible shares			2,395,850				7,187,542
Description of terms of conversion feature							ii) a December 2015 Note with a principal amount of $1.00 for each $0.86956 for each $1.00 paid by each purchaser for such purchaser’s December 2015 Note; and (iii) December 2015 Warrants to purchase up to a number of shares of Common Stock equal to 100% of such purchaser’s December 2015 Note principal amount divided by $0.12 (“December 2015 Purchaser Conversion Price”), the conversion price in effect on the Initial Closing Date, with a per share exercise price equal to $0.30, subject to adjustment.
Successor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Conversion rate	$ 0.08
Successor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Common Stock [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	0.08
Successor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Warrant [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	$ 0.30
Warrant exercisable term	5 years
Predecessor [Member]
Unamortized debt discount						$ 31,500
Interest expense						$ 33,270
Predecessor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Conversion rate	$ 0.08
Predecessor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Common Stock [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	0.08
Predecessor [Member] \| Second Consent Waiver and Modification Agreement [Member] \| Warrant [Member] \| Convertible Promissory Note [Member] \| Subsequent Event [Member]
Share price (in dollars per share)	$ 0.30
Warrant exercisable term	5 years